Blog

A Social Media Inspired Space for Learning

  • The Science on the Origin of Life

    Have you ever wondered where life began? How did we as human beings came into existence? While slightly off the topic of our normal blog posts, these things are fun to to think about and our own Andrew Kornfeld, Director of Communications at Recovery Without Walls interviewed one of the worlds leading authorities on the science of how life began from the University of California, Santa Cruz. It involves, a lot of chemistry, some asteroids and some soapy hot volcanic pits. Read his article here! https://www.dropbox.com/s/m3by13nenvo4npq/Scientific%20Slug%20Fall%202013.pdf
    and check out the cool graphic below!

  • Could a Tablet of Buprenorphine Have Saved the Life of Philip Seymour Hoffman?

    Philip Seymour Hoffman died from “acute mixed drug intoxication,” according to the newly released official autopsy. The cocktail of controlled substances that led to his tragic death included heroin, cocaine, benzodiazepines, and amphetamines, as reported by Julie Bolcer of the New York City Medical Examiner’s Office.

    We find it noteworthy that, in addition to the dozens of heroin bags found in his apartment, Hoffman also had tablets of the specialized analgesic and addiction drug, buprenorphine. When mixing drugs, opiates greatly exacerbate the likelihood of overdose. Could a tablet of buprenorphine have saved the life of Philip Seymour Hoffman?

    Buprenorphine has a unique effect on the human nervous system. Like other opiates, such as OxyContin (oxycodone), Vicodin (hydrocodone) and heroin (known in England as diacetylmorphine), buprenorphine activates the μ-opioid receptor. However, buprenorphine has a higher binding affinity for the receptor than any other opioid, while simultaneously acting in a “partial” or less disruptive way. As a result, respiratory depression and cardiac arrest (syndromes associated with heroin and other full-agonist opiates, such as oxycodone) are significantly less associated with buprenorphine. Consequently, buprenorphine can actually reduce the binding of these dangerous opiates from the μ-opiate receptor and prevent fatal outcomes. In addition, this unique binding often reduces neuropathic and other complex types of pain untouched by other opioids.

    Buprenorphine was the result of a forty-year search for a non-euphoric but effective painkiller and, when used in addiction, causes much less craving and a minimal “high” for most addicts. Therefore, it can often miraculously stabilize the lives of both addiction and pain patients.

    What if some of the buprenorphine in Hoffman’s apartment had been in his system on the night of his death on February 1st? Is it plausible that this could have affected the outcome of his tragic situation and given him another chance to get back into recovery?

    We believe, that this is highly possible. Dr. Kornfeld has been treating patients with buprenorphine since we started using it for pain patients in the 1990s and he has seen its life saving capacities in potential overdose situations on numerous occasions.

    How can we, as practitioners and as a society, utilize this piece of information to prevent tragedies in the future? First, we can spread knowledge of the potential medical uses of buprenorphine for both addiction and chronic pain. Second, we can endeavor to correct dangerous misconceptions that using buprenorphine is just substituting one addiction for another – an impression influenced by the misguided two-part investigation last year by New York Times reporter Deborah Sontag. Third, we can encourage physicians to take the short course in addiction training required by law to prescribe buprenorphine safely for addiction and persuade insurance carriers to pay for this life-saving treatment. Fourth, when evidence surfaces of buprenorphine misuse, we can deploy public health educational teams to better train physicians, patients, and health administrators how to do a better job with this unique drug.

    On April 10, 2014 in Orlando, Florida, prior to the Annual Medical Scientific Conference of the American Society of Addiction Medicine, I have the honor of joining a panel of experts discussing “Pain and Addiction: Common Threads.” We will be joined by 300 physicians and others interested in this field to discuss the latest information on buprenorphine. Consider registering for this program while seats are available.

  • Has the FDA Approved the Next OxyContin?

    The FDA has approved a long-acting hydrocodone (the principle component of Vicodin or Norco) based drug called “Zohydro” for chronic pain. This is another full acting opiate, with high addiction and overdose potential. The successful uses of buprenorphine, as a first line analgesic, are still not fully recognized in the United States. It is our belief that a more enlightened public health strategy needs to be developed. This strategy would include both buprenorphine and addiction training education for all physicians treating pain. In this way, these more dangerous prescription opioids will no longer contribute to the nearly 15,000 preventable deaths yearly (CDC.org). Read more: http://www.cnn.com/2014/02/26/health/zohydro-approval/

    At Recovery Without Walls, we carefully use buprenorphine in the treatment of chronic pain. As a drug with less abuse potential, greatly reduced overdose risk, and a higher efficacy for a myriad of pain conditions, buprenorphine can be part of an evidence-based medicine approach we advocate. Get help now. Visit www.recoverywithoutwalls.com or call us at (415) 383-2949.

  • Bill, Barrack, and Neil

    It’s always nice to see our two favorite scientists with the president.

  • A Life Philosophy

    What can we all learn from this?

  • Neuropharmacology Interactive

    From the University of Utah, a fun interactive of how illicit drugs (specifically drugs of abuse) work in the mammalian brain. Science is knowledge, knowledge is power. http://learn.genetics.utah.edu/content/addiction/mouse/

  • India Reforms Drug Laws Regarding Prescription Pain Medications

    The US is not the only country reforming drug policy. In India, for some patients suffering from chronic pain, access to proper medications was historically very difficult. With regulations still in place, these laws are now being reformed. http://www.hrw.org/news/2014/02/21/india-major-breakthrough-pain-patients

  • E-Cigarettes in Rural Jails

    While many areas around the United States are working to Ban e-cigarettes. Some places however are welcoming them: rural county jails. It is reported that it can calm inmates down who crave a smoke. Is this a good harm reduction effort? http://www.nytimes.com/2014/01/24/us/in-rural-jails-a-calming-vapor.html

  • Future of Pain Treatment?

    One day pain treatment could be disease specific and not just symptom specific.

    http://www.ted.com/talks/elliot_krane_the_mystery_of_chronic_pain.html

  • What Drugs Actually Kill People

    “Nearly three-quarters of the pharmaceuticals deaths are opioid analgesics—prescription painkillers like OxyContin and Vicodin. And while cocaine, heroin and alcohol are all responsible for enough deaths to warrant their own stripes on the chart, many popular illegal drugs—including marijuana and LSD—are such a tiny blip as to be invisible.” – PopSci

    http://www.popsci.com/science/article/2013-04/which-drugs-actually-kill-americans?src=SOC&dom=fb

Page 3 of 4«1234»

You can also buy Kamagra Oral Jelly. It is very tasty and nice smell all sorts of fruits and berries. If you love the berries as well as a cat, you cann't have kamagra jelly large tablespoon straight from the pot or drink if you are very hungry. There are different colors and flavors . Everyone will find something for themselves